Search Results
Oct 03, 2025, 09:00 ET Mitsubishi Tanabe Pharma America to Present New Data on Investigational ND0612 at the 2025 International Congress of Parkinson's Disease and Movement Disorders®
NCT04006210), which evaluated ND0612 vs. standard of care in people with PD experiencing motor fluctuations. The study assessed key endpoints, including ON time and OFF time, along with pharmacokinetics,
More news about: Mitsubishi Tanabe Pharma America
Oct 03, 2025, 05:58 ET Active Pharmaceutical Ingredients (API) Market to Surpass US$ 428.5 Billion by 2033 as Biotech APIs and Oncology Applications Lead Global Growth | DataM Intelligence
modest delays in raw material shipment or customs clearance can lead to supply gaps. Reshoring pressure vs cost, scale and regulatory burden Efforts in the U.S. and EU to bring API production back domestically are underway,
More news about: DataM Intelligence 4 Market Research LLP
Oct 02, 2025, 20:40 ET Far Eastern New Century verricht baanbrekend werk op gebied van duurzaam schoeisel met 's werelds eerste gecommercialiseerde tussenzolen gemaakt van afgedankte PET-flessen
FENC, opgericht in 1949 als moedermaatschappij van het conglomeraat Far Eastern Group, is een internationaal bedrijf gevestigd in Taiwan, actief in de VS, Japan, China, Vietnam, Maleisië en de Filippijnen en verkoopt aan bekende merken over de hele wereld. FENC is 's werelds grootste leverancier van food-grade
More news about: Far Eastern New Century Corporation
Oct 02, 2025, 18:37 ET FDA Approves Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
patients >65 years of age and patients <65 years of age (33% vs. 29%, respectively). There was a higher incidence of Grade 3 or 4 adverse reactions in patients ≥65 years of age compared to younger patients (45% vs. 31%, respectively). HEPATIC IMPAIRMENT
More news about: Jazz Pharmaceuticals plc
Oct 02, 2025, 15:35 ET Updated CA Insurance Department Data Shows Time To Rate Approvals Same With or Without Intervenors, Public Citizen Chimes In Against Revenge Regulations, says Consumer Watchdog
when CDI acts on its own (10 months with CW vs 9.8 months just CDI). Approvals are approximately 45 days faster on average for Consumer Watchdog auto insurance challenges as opposed to when CDI reviews auto insurance rate hikes alone (6.5 months with CW vs 8 with just CDI). In
More news about: Consumer Watchdog
Oct 02, 2025, 14:43 ET Campanha LG Reimagine convida a ressignificar o dia a dia com geladeiras LG
reorganizou suas operações em quatro divisões de negócios:Home Appliance Solution (HS), Media Entertainment Solution (MS), Vehicle Solution (VS) e Eco Solution (ES), redefinindo seus papéis e identidades para acelerar sua visão de futuro até 2030. Em 2024, as quatro divisões combinadas
More news about: LG Electronics Brasil
Oct 02, 2025, 14:16 ET Elevate Your Escape: Updates on The Palm Beaches' Newest Hotels, Dining, Events & Attractions
Presented by SoFi will tee off at the new SoFi Center in Palm Beach Gardens for its second season in December. The opening match features Atlanta Drive GC vs. New York Golf Club. This groundbreaking league blends live-action golf with next-gen simulator technology, offering a fast-paced, immersive experience
More news about: Discover The Palm Beaches
Oct 02, 2025, 13:40 ET PROSECCO'S AMERICAN SUCCESS STORY: FROM ZERO TO $500 MILLION IN 15 YEARS
According to Vinitaly and the Unione Italiana Vini (UIV), Prosecco's U.S. market share exceeds the average for Italian wine (27% vs. 24%), reaching a record $531 million in 2024. This represents a nearly uninterrupted upward trend, aside from a slight pause in 2020, followed
More news about: Vinitaly.USA
Oct 02, 2025, 11:00 ET FDA-Cleared Lotus Catheter Accelerates Global Expansion, Backed by Peer-Reviewed Zero-UTI Study and 500,000+ Uses
risk): Lotus ~4.8 mL mean residual vs. Foley ~50–100 mL commonly trapped by the balloon—less pooling means fewer bacterial growth opportunities. Infections: Lotus: 0 CAUTIs observed in a 50-patient study vs. Foley: symptomatic UTIs
More news about: Lotus Medical Technologies LLC
Oct 02, 2025, 09:00 ET Mitsubishi Tanabe Pharma America to Present Eight ALS Research Posters at 2025 NEALS Annual Meeting
reported in RADICAVA® (edaravone)-treated patients and at least 2% more frequently than placebo were contusion (15% vs 9%), gait disturbance (13% vs 9%), and headache (10% vs 6%), respectively. In an open label study, fatigue was also observed in 7.6% of patients receiving RADICAVA ORS.
More news about: Mitsubishi Tanabe Pharma America
Oct 02, 2025, 08:41 ET College Essay Advisors Launch Ethical AI Platform and New Book as Universities Ban ChatGPT
collegeess.ai with a free trial. Premium plans start at $29/month (6-month access) vs. $150+ per hour for private counseling, with the most popular 3-month plan at $39/month covering the whole application season and a 1-month option at
More news about: College Essay Advisors
Oct 02, 2025, 08:08 ET Eisai Highlights Breadth of Oncology Research at ESMO 2025, Featuring 5-Year Survival Data from Study 309/KEYNOTE-775
Lenvatinib plus pembrolizumab (L+P) vs treatment of physician's choice (TPC) for advanced endometrial cancer (EC): 5-Year outcomes from Study 309/KEYNOTE-775
More news about: Eisai Inc.
Oct 02, 2025, 08:03 ET Ambition Has a Cost That's Not Always Worth It
It's a narrative guide that explores the same themes that Gillespie has taught in boardrooms and on the mat — fear of change, loss of identity, risk vs. reward — and invites readers into a journey of clarity and alignment. Key Messages: Drawing from her
More news about: Anusia Gillespie
Oct 01, 2025, 23:30 ET River Public Affairs Group Partners with Broadcast Influencers to Amplify Advocacy Efforts
with advocacy messages designed to have the greatest impact through relatable voices that audiences respect. Affinity Marketing vs. Standard Marketing Affinity marketing through trusted voices helps cut through the barrage of advertising and marketing noise
More news about: River Public Affairs Group
Oct 01, 2025, 17:22 ET FOX NEWS CHANNEL BEATS CBS AND ABC IN THIRD QUARTER AND REMAINS LEADER IN ALL OF TELEVISION YEAR TO DATE
delivered 1.3 million viewers and 99,000 in the 25-54 demo. 3Q'25 NIELSEN NUMBERS VS. 3Q'24 (Monday-Sunday, Live + Same Day): TOTAL DAY+
More news about: Fox News Network, LLC
Oct 01, 2025, 16:18 ET Country star Eric Church is UNC-Chapel Hill's 2026 Spring Commencement speaker
embarking on a fall tour in support of his eighth studio album, "Evangeline vs. the Machine," released May 2. He released a single from that album, called "
More news about: University of North Carolina at Chapel Hill
Oct 01, 2025, 10:00 ET Bridgestone Launches V-Steel Highway Service 3 Crane Tire
operational hours and wear for the Bridgestone VHS2 tire vs. the Bridgestone VHS3 tire in size 445/95R25-174F. Results may vary. 3 Tire weight based on internal data comparing VHS2 vs. VHS3 445/95R25 - 174F. Results may vary.
More news about: Bridgestone Americas, Inc.
Oct 01, 2025, 09:28 ET F-Secure Sounds the Alarm on Global Scam Pandemic with 2025 Scam Intelligence & Impacts Report
Artificial Intelligence in 2025 The Silent Toll of Scams: Breaking the Cycle of Shame and Inaction Risk vs Reality: Crypto Feels Dangerous—But Is Fear Justified? The Future of Trust: Reckoning with an Increasingly Unreliable
More news about: F-Secure
Oct 01, 2025, 09:01 ET Laguna Diagnostics Awarded Second U.S. Patent for Rapid Blood Tests to Differentiate Schizophrenia and Bipolar Disorder, Expanding IP Portfolio in $3B Market
specificity derived from transcript abundance. Diagnostic performance was exceptionally strong, with AUCs of 0.995 (NC vs. BD+SZ), 0.967 (NC vs. SZ), 0.987 (NC vs. BD), and 0.996 (SZ vs. BD). *Ribonucleic acid (RNA) is a polymeric molecule essential for most
More news about: Laguna Diagnostics, LLC
Oct 01, 2025, 09:00 ET The Gallagher Cup - The Rematch: Ireland vs. All Blacks
Oct. 1, 2025 /PRNewswire/ -- TEG Rugby Live and Gallagher are proud to announce the Gallagher Cup – The Rematch: Ireland vs. All Blacks, at Soldier Field on Saturday, November 1, 2025 at 3:00 PM CST.
More news about: Gallagher
Oct 01, 2025, 08:19 ET Semaglutida oral 25 mg da Novo Nordisk (Wegovy® em comprimido*) proporciona perda de peso de 16,6% em pessoas com obesidade, aponta novo estudo
gastrointestinais com semaglutida oral 25 mg foram geralmente de gravidade leve a moderada e transitórios; os mais comuns foram náusea (46,6% vs. 18,6% para placebo) e vômito (30,9% vs. 5,9% para placebo).¹ Eventos adversos que levaram à descontinuação permanente do tratamento foram de 6,9% (semaglutida oral 25 mg)
More news about: Novo Nordisk
Oct 01, 2025, 08:15 ET TAYLOR DEVICES ANNOUNCES FIRST QUARTER RESULTS
first quarter earnings of $2,666,655. "While our sales and net earnings for this fiscal year first quarter finished a bit down vs. the record highs we set last year, 15% and 18% respectively, the sales of $9.9M and net earnings of $2.2M achieved this year are both better than their
More news about: Taylor Devices, Inc.
Oct 01, 2025, 08:00 ET Dutch Bros and Chick-fil-A Lead in Satisfaction, Taco Bell Dominates Speed, and Raising Cane's Excels in Food Quality in Intouch Insight's 25th Annual Drive-Thru Study
compared to just 22% when the service wasn't friendly. When orders were rated as friendly, order accuracy was also higher (89% vs. 70%), and speed was faster (5 minutes and 23 seconds vs. 6 minutes and 57 seconds). Communication makes the difference. Clear
More news about: Intouch Insight
Oct 01, 2025, 08:00 ET Back Market's First Store Aims to Break the Fast Tech Upgrade Cycle
Key features of the store include: Hands-On Experience: A "new vs. refurbished" interactive that challenges visitors to spot the difference and provides an opportunity to interact directly with refurbished tech.
More news about: Back Market
Oct 01, 2025, 08:00 ET First increase in ransomware attacks in three years driven by new technology
attacks The study showed an overall reduction in phishing attacks over the past 12 months (52.3% in 2024 vs 46% in 2025). However, the increase in the use of AI-generated phishing was identified by over three quarters of CISOs (77%) as a growing threat.
More news about: Hornetsecurity Limited